Singapore markets closed

Seagen Inc. (SGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
133.47-5.87 (-4.21%)
At close: 04:00PM EDT
134.30 +0.83 (+0.62%)
After hours: 05:23PM EDT
Full screen
Loading interactive chart…
  • Business Wire

    Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combination With Trastuzumab in HER2-Positive Metastatic Colorectal Cancer

    BOTHELL, Wash., May 23, 2022--Seagen Inc. (Nasdaq:SGEN) today announced positive topline results from the pivotal phase 2 MOUNTAINEER clinical trial investigating TUKYSA® (tucatinib) in combination with trastuzumab in patients with previously treated HER2-positive metastatic colorectal cancer (mCRC). Data from this trial will form the basis of a planned supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) under the FDA’s Accelerated Approval Program. Merck, known as M

  • Business Wire

    Seagen Announces Resignation of President, Chairman & CEO Clay Siegall

    BOTHELL, Wash., May 16, 2022--Seagen Inc. (Nasdaq: SGEN) today announced that the Board of Directors yesterday accepted the resignation of Clay Siegall, Ph.D., as President, CEO and member of the Board of Directors. Felix J. Baker, Ph.D., formerly Lead Independent Director, has been appointed Chair of the Board of Directors. Roger Dansey, M.D., Seagen’s Chief Medical Officer since 2018, will continue as interim CEO until a new CEO is found.

  • Business Wire

    Seagen President, CEO and Chairman Clay Siegall Takes Leave of Absence

    BOTHELL, Wash., May 09, 2022--The Board of Directors of Seagen Inc. (Nasdaq: SGEN) today announced that President, CEO and Chairman Clay Siegall, Ph.D. is on a leave of absence. The company is aware of an alleged incident of domestic violence that occurred recently at Dr. Siegall’s home. Dr. Siegall has denied these allegations and has informed the company that he is engaged in a divorce. The Board of Directors has formed a committee of independent directors and is conducting a thorough investig